Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
Frontiers in Pharmacology, 2022 Antiplatelet therapy, mainly consisting of aspirin and P2Y12 receptor antagonists, is the cornerstone of the pharmacological treatment and prevention of atherothrombotic diseases.
Georges Jourdi +11 more
doaj +1 more source
A hopeful therapy for Niemann-Pick C diseases [PDF]
, 2017 Not abstract ...
Erickson, Robert P. +1 more
core +1 more source
ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS
Рациональная фармакотерапия в кардиологии, 2016 The problem of antiplatelet drug choice in patients with atrial fibrillation is discussed. Authors give special attention to new alternative drugs for prevention of thrombotic complications apart from old known antiplatelet drugs.
M. Yu. Gilyarov, V. A. Sulimov
doaj +1 more source
ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY
Рациональная фармакотерапия в кардиологии, 2017 Current guidelines for the management of atrial fibrillation (AF) recommend using anticoagulants as first-line drugs for stroke prevention, but in real medical practice antiplatelet drugs are often prescribed to elderly patients.
E. А. Ushkalova +2 more
doaj +1 more source
Generic versus brand-name drugs used in cardiovascular diseases [PDF]
, 2016 This meta-analysis aimed to compare the efficacy and adverse events, either serious or mild/moderate, of all generic versus brand-name cardiovascular medicines.
Boccia, Stefania +9 more
core +1 more source
RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
Рациональная фармакотерапия в кардиологии, 2015 The clinical, cell and genetic factors are distinguished among reasons for resistance to antiplatelet drugs. There are many methods to detect sensitivity to antiplatelet drugs, but they all have disadvantages.
D. H. Aynetdinova +2 more
doaj +3 more sources
Reviews in Cardiovascular MedicineCoronary atherosclerosis (or coronary heart disease [CHD]) is a common cardiovascular disease that seriously damages human health. Percutaneous coronary stent implantation represents the primary treatment option for severe CHD in clinical practice ...
Ji-tong Yang +3 more
doaj +1 more source
Antiplatelet drugs and the perioperative period: What every urologist needs to know
Indian Journal of Urology, 2009 Antiplatelet agents like aspirin and clopidogrel are widely used for indications ranging from primary and secondary prevention of myocardial infarction or stroke to prevention of coronary stent thrombosis after percutaneous coronary interventions.
Pawan Vasudeva +4 more
doaj +1 more source
DENTAL CONSIDERATIONS IN PATIENTS TAKING NEW ANTIPLATELET AND ANTICOAGULANT DRUGS [PDF]
Journal of IMAB, 2020 Atherosclerosis and the resulting cardiovascular and cerebrovascular diseases (myocardial infarction, coronary artery disease and stroke) are the leading cause of mortality and morbidity in the developed countries.
Atanaska S. Dinkova +2 more
doaj +1 more source
Developing a complex intervention to improve prescribing safety in primary care:mixed methods feasibility and optimisation pilot study [PDF]
, 2014 Objectives (A) To measure the extent to which different candidate outcome measures identified high-risk prescribing that is potentially changeable by the data-driven quality improvement in primary care (DQIP) intervention.(B) To explore the value of ...
Dreischulte, Tobias +2 more
core +7 more sources